These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24724970)

  • 1. Feto-maternal correlation of PTX3, sFlt-1 and PlGF in physiological and pre-eclamptic pregnancies.
    Algeri P; Ornaghi S; Bernasconi DP; Cappellini F; Signorini S; Brambilla P; Urban G; Vergani P
    Hypertens Pregnancy; 2014 Aug; 33(3):360-70. PubMed ID: 24724970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction.
    Schoofs K; Grittner U; Engels T; Pape J; Denk B; Henrich W; Verlohren S
    J Perinat Med; 2014 Jan; 42(1):61-8. PubMed ID: 23929878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
    Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
    Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
    Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma sFlt-1-to-PlGF ratio is correlated with inflammatory but not with oxidative stress in Chinese preeclamptic women.
    Ouyang YQ; Li SJ; Zhang Q; Xiang WP; Shen HL; Chen HP; Chen H; Chen HZ
    Arch Gynecol Obstet; 2009 Jul; 280(1):91-7. PubMed ID: 19099313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ; Åsvold BO; Eskild A
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can detection of late-onset PE at triage by sflt-1 or PlGF be improved by the use of additional biomarkers?
    Kaufmann I; Rusterholz C; Hösli I; Hahn S; Lapaire O
    Prenat Diagn; 2012 Dec; 32(13):1288-94. PubMed ID: 23108782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
    Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
    Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
    Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
    Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
    Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
    J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.
    Dröge LA; Höller A; Ehrlich L; Verlohren S; Henrich W; Perschel FH
    Pregnancy Hypertens; 2017 Apr; 8():31-36. PubMed ID: 28501276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia.
    Hamad RR; Eriksson MJ; Berg E; Larsson A; Bremme K
    Acta Obstet Gynecol Scand; 2012 Jan; 91(1):50-56. PubMed ID: 21751969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.